دورية أكاديمية
أعرض في EDS

Anti-Microbial Drug Metronidazole Promotes Fracture Healing: Enhancement in the Bone Regenerative Efficacy of the Drug by a Biodegradable Sustained-Release In Situ Gel Formulation.

التفاصيل البيبلوغرافية
العنوان: Anti-Microbial Drug Metronidazole Promotes Fracture Healing: Enhancement in the Bone Regenerative Efficacy of the Drug by a Biodegradable Sustained-Release In Situ Gel Formulation.
المؤلفون: Duggal S; Division of Endocrinology, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India., Sharma S; Division of Endocrinology, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India., Rai N; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.; Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India., Chauhan D; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.; Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India., Upadhyay V; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.; Division of Cancer Biology, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India., Srivastava S; Division of Cancer Biology, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India., Porwal K; Division of Endocrinology, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India., Kulkarni C; Division of Endocrinology, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India., Trivedi AK; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.; Division of Cancer Biology, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India., Gayen JR; Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India., Mishra PR; Division of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India., Chattopadhyay N; Division of Endocrinology, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India.; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India., Pal S; Division of Endocrinology, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India.; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University, Atlanta, GA 30322, USA.; Division of Medical Research, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology (SRM IST), Kattankulathur 603203, India.
المصدر: Biomedicines [Biomedicines] 2024 Jul 18; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 18.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2013]-
مستخلص: Nitroimidazoles comprise a class of broad-spectrum anti-microbial drugs with efficacy against parasites, mycobacteria, and anaerobic Gram-positive and Gram-negative bacteria. Among these drugs, metronidazole (MTZ) is commonly used with other antibiotics to prevent infection in open fractures. However, the effect of MTZ on bone remains understudied. In this paper, we evaluated six nitroimidazole drugs for their impact on osteoblast differentiation and identified MTZ as having the highest osteogenic effect. MTZ enhanced bone regeneration at the femur osteotomy site in osteopenic ovariectomized (OVX) rats at the human equivalent dose. Moreover, in OVX rats, MTZ significantly improved bone mass and strength and improved microarchitecture compared to the vehicle-treated rats, which was likely achieved by an osteogenic mechanism attributed to the stimulation of the Wnt pathway in osteoblasts. To mitigate the reported neurological and genotoxic effects of MTZ, we designed an injectable sustained-release in situ gel formulation of the drug that improved fracture healing efficacy by 3.5-fold compared to oral administration. This enhanced potency was achieved through a significant increase in the circulating half-life and bioavailability of MTZ. We conclude that MTZ exhibits osteogenic effects, further accentuated by our sustained-release delivery system, which holds promise for enhancing bone regeneration in open fractures.
References: Biochem Pharmacol. 2019 Jun;164:34-44. (PMID: 30885766)
Mater Today Bio. 2022 Aug 27;16:100409. (PMID: 36090611)
Calcif Tissue Int. 2024 Mar;114(3):295-309. (PMID: 38102510)
Gels. 2022 Mar 08;8(3):. (PMID: 35323282)
Cureus. 2022 Jul 11;14(7):e26731. (PMID: 35967145)
PLoS One. 2012;7(3):e33021. (PMID: 22427932)
Int J Mol Sci. 2019 Dec 03;20(23):. (PMID: 31816823)
Calcif Tissue Int. 2022 Aug;111(2):196-210. (PMID: 35451627)
Malays Orthop J. 2019 Jul;13(2):1-10. (PMID: 31467644)
Biomaterials. 2015 Jul;56:92-103. (PMID: 25934283)
Int J Pharm. 2024 Mar 5;652:123819. (PMID: 38242256)
Bone Jt Open. 2021 Apr;2(4):227-235. (PMID: 33843259)
PM R. 2011 Feb;3(2):132-42. (PMID: 21333952)
ACS Appl Mater Interfaces. 2021 Apr 21;13(15):17300-17315. (PMID: 33830736)
ACS Biomater Sci Eng. 2016 Nov 14;2(11):2001-2010. (PMID: 33440536)
Sci Rep. 2020 Jan 13;10(1):195. (PMID: 31932603)
Acta Pol Pharm. 2010 May-Jun;67(3):217-23. (PMID: 20524422)
Eur J Pharmacol. 2021 Dec 15;913:174634. (PMID: 34785210)
J Orthop Res. 2019 Oct;37(10):2067-2076. (PMID: 31329305)
Crit Rev Eukaryot Gene Expr. 2009;19(3):171-80. (PMID: 19883363)
Trends Endocrinol Metab. 2013 Jan;24(1):31-9. (PMID: 23245947)
J Orthop Res. 2019 Jan;37(1):35-50. (PMID: 30370699)
Prostaglandins. 1981 Mar;21(3):401-11. (PMID: 7232765)
Clujul Med. 2013;86(3):240-4. (PMID: 26527955)
Int J Mol Sci. 2019 Oct 17;20(20):. (PMID: 31627424)
Pharmaceutics. 2019 Mar 21;11(3):. (PMID: 30901930)
Materials (Basel). 2019 Apr 04;12(7):. (PMID: 30987272)
Injury. 2021 Nov;52(11):3498-3504. (PMID: 34420689)
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD000244. (PMID: 20238310)
J Tissue Eng Regen Med. 2022 Nov;16(11):961-976. (PMID: 36112528)
J Clin Med. 2022 Dec 16;11(24):. (PMID: 36556077)
Sci Rep. 2016 Sep 28;6:34069. (PMID: 27677842)
Semin Plast Surg. 2009 May;23(2):90-9. (PMID: 20567731)
J Bone Miner Res. 2021 Jul;36(7):1403-1415. (PMID: 33831261)
Res Pharm Sci. 2015 Nov-Dec;10(6):466-76. (PMID: 26779266)
Assay Drug Dev Technol. 2006 Aug;4(4):387-96. (PMID: 16945012)
J Nutr Biochem. 2017 Jun;44:22-34. (PMID: 28343085)
Drug Deliv. 2016 Oct;23(8):2726-2735. (PMID: 26289210)
J Orthop Res. 2022 Mar;40(3):541-552. (PMID: 35076097)
Pharmaceutics. 2020 Mar 13;12(3):. (PMID: 32183144)
Int J Mol Sci. 2022 Feb 04;23(3):. (PMID: 35163708)
Indian J Pharm Sci. 2009 May;71(3):242-51. (PMID: 20490289)
Antimicrob Agents Chemother. 2012 Aug;56(8):4046-51. (PMID: 22615289)
Calcif Tissue Int. 2019 Sep;105(3):294-307. (PMID: 31175387)
Front Pharmacol. 2019 Apr 10;10:367. (PMID: 31024321)
World J Stem Cells. 2024 Feb 26;16(2):102-113. (PMID: 38455105)
J Ethnopharmacol. 2019 May 10;235:8-18. (PMID: 30703497)
Int Orthop. 2007 Apr;31(2):223-8. (PMID: 16710734)
J Bone Miner Res. 2006 Apr;21(4):637-46. (PMID: 16598384)
J Korean Assoc Oral Maxillofac Surg. 2022 Apr 30;48(2):94-100. (PMID: 35491140)
Bone. 2022 Jun;159:116377. (PMID: 35248788)
J Bone Miner Res. 1995 Jan;10(1):132-8. (PMID: 7747620)
معلومات مُعتمدة: MLP 2035 Council of Scientific and Industrial Research
فهرسة مساهمة: Keywords: anti-microbial drug; fracture healing; in situ gel formulation; osteoblast differentiation; osteogenic
تواريخ الأحداث: Date Created: 20240727 Latest Revision: 20240729
رمز التحديث: 20240729
مُعرف محوري في PubMed: PMC11274654
DOI: 10.3390/biomedicines12071603
PMID: 39062176
قاعدة البيانات: MEDLINE
الوصف
تدمد:2227-9059
DOI:10.3390/biomedicines12071603